D-0026-2022 Class II Terminated
FDA drug recall D-0026-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Oct 5, 2021 and is designated Class II. Reason for recall: CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle. The recall status is terminated (terminated Dec 6, 2022). Affected quantity: 8,976 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 27, 2021
- Initiation Date
- Oct 5, 2021
- Termination Date
- Dec 6, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,976 bottles
Product description
Omeprazole Delayed-Release Capsules, 20 mg* (equivalent to 20.6 mg omeprazole magnesium), 24 Hour, 14-count capsules per bottle within a carton, Distributed by Cardinal Health, Dublin, OH 43017, NDC 70000-0232-1
Reason for recall
CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.
Distribution pattern
Nationwide in the USA
Code information
BT001594C
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0026-2022
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026